EDITORIAL
Editorial Board Irene Anderson
Principal Lecturer Tissue Viability, Reader in Learning and Teaching in Healthcare Practice, University of Hertfordshire
Industry and clinician: collaboration is key
Martyn Butcher
Independent Tissue Viability & Wound Care Consultant; Associate Lecturer, University of Plymouth; Research Nurse (Tissue Viability), Northern Devon Healthcare Trust (Honorary post)
Keith Cutting
Visiting Professor, Buckinghamshire New University, Uxbridge; Director, Perfectus Medical
Jemell Geraghty
Clinical Nurse Specialist, Tissue Viability, Royal Free Hamstead NHS Trust
Steve Jeffery
Professor, Wound Study, Birmingham City University, Fellow of the Royal College of Surgeons of Edinburgh, England and Glasgow
Editor Julie Smith Subeditor Lauran Elsden Associate Publisher Chloe Benson Publishing Director Anthony Kerr If you would like to submit an article for publication in this supplement please contact Julie Smith on 020 7738 5454 or [email protected]
MA Healthcare Ltd is part of the Mark Allen Group
www.markallengroup.com The British Journal of Nursing is published by MA Healthcare Ltd, St Jude’s Church, Dulwich Road, London SE24 0PB Tel: 020 7738 5454 Editorial: 020 7501 6716 Sales: 020 7501 6726 Subscriptions: 0800 137201 Email: [email protected] Websites: www.britishjournalofnursing.com
© MA Healthcare Ltd, 2012. All rights reserved. No part of the British Journal of Nursing may be reproduced, stored in a retrieval system, or transmitted in any form or by any means electronic, mechanical, photocopying, recording, or otherwise without prior written permission of the Publishing Director. Print: Pensord Press Ltd, Blackwood, NP12 2YA Cover picture: istockphoto.com
The paper used within this publication has been sourced from Chain-of-Custody certified manufacturers, operating within international environmental standards, to ensure sustainable sourcing of the raw materials, sustainable production and to minimise our carbon footprint.
T
issue viability has many faces in health care today. We present foremost for patient care, however, our evolving role as specialist, innovator, researcher and advocator continues to demand that we meet expectation for high-quality, evidence-based practice and measurable outcomes. Measuring the domains of quality in wound care and tissue viability services has been outlined in the Department of Health white paper (2010) as safety, effectiveness and experience.While we are confident that we provide care that meets the domain of quality and patient experience, future challenges in promoting and sustaining services will require us to prove we have the specialist skills to operate in our field. As specialists we must meet locally with our fellow tissue viability colleagues and nationally to share and learn from each other. The NHS demands more effective and efficient use of its resources in conjunction with greater budgetary constraints, both of which have impacted upon availability and access to wound-care education (Ousey et al, 2011). The consequence of increasing constraints to reduced access and funds to education and training can be transferred to patient outcomes and in reaction to this we have had to find other ways of outsourcing flexible education and training. The wound-care industry has responded to this with the introduction of non-promotional clinical teams, demonstrating a commitment beyond sales figures. This ‘value-added service’ has provided much-needed support to tissue viability in meeting NHS incentives and the needs of tissue-viability nurses. Questions will always arise between industry and clinician in terms of motivation, bias and credibility, however, we cannot overlook that industry play a pivotal role in often providing the framework to how we access education. Industry is actively involved in many of our tissue viability forums and bring new dimensions and productivity to how we manage and implement. A key example of this is the new consensus document Effective debridement in a changing NHS (2013), which provides us with the theory and practical steps to effectively facilitate optimum wound healing through debridement. With the release of this seminal document we had begun to question our own skills and competencies; were they up to date and valid, were they universityaccredited, did we need an update?
British Journal of Nursing, 2013 (Tissue Viability Supplement), Vol 22, No 12
An exciting opportunity arose this year in London and the South East where industry and clinician came together to propose new ways of developing sharp debridement skills; this was in response to a lack of formal accredited training within the London area. Chair for the Tissue Viability Nurse Forum South, (TVNFS) Kumal Rajpaul approached the clinical team from Urgo Medical to work together to develop a new sharp-debridement course.The development of the course was based on a university module, however, it demanded a fresh approach to accommodate training around new study-leave allowances.The revised course was based on condensing the taught sessions into 3 days and basic knowledge was delivered in the form of a precourse reading manual.These adaptations underwent peer review from forum members periodically and any changes were made by the collaborative efforts of both TVNFS and the clinical support from Urgo Medical. The course was later submitted to EWMA for endorsement as valid for sharp-debridement training and received its primary approval in April 2013. Feedback was extremely positive and while the first 15 attendees are currently working on their competencies, the waiting list for the next course is already growing. The course is recognised as a vital part of wound education for specialist nurses in providing high-quality care for patients, ultimately delivering improved patient outcomes. It has also opened up new possibilities for those of us involved in tissue viability forums; we have the skills to share and learn from each other so firstly let us consider what we can offer in terms of skill development and specialist placement and competency. Patient care is about excellence and who better to teach this than those BJN of us who provide it. Department of Health (2010) Equity and excellence. Liberating the NHS. DH, London Ousey K et al (2011) How can we maintain effective and relevant wound care education? Wounds UK. 7(1): 145-7 Wounds UK (2013) Effective debridement in a changing NHS: a UK consensus. Wounds UK, London
Jemell Geraghty Jemell is Clinical Nurse Specialist in Tissue Viability, the Royal Free Hampstead NHS Trust
S3
British Journal of Nursing. Downloaded from magonlinelibrary.com by 130.194.020.173 on November 26, 2015. For personal use only. No other uses without permission. . All rights reserved.
Editorial Board Irene Anderson
Principal Lecturer Tissue Viability, Reader in Learning and Teaching in Healthcare Practice, University of Hertfordshire
Industry and clinician: collaboration is key
Martyn Butcher
Independent Tissue Viability & Wound Care Consultant; Associate Lecturer, University of Plymouth; Research Nurse (Tissue Viability), Northern Devon Healthcare Trust (Honorary post)
Keith Cutting
Visiting Professor, Buckinghamshire New University, Uxbridge; Director, Perfectus Medical
Jemell Geraghty
Clinical Nurse Specialist, Tissue Viability, Royal Free Hamstead NHS Trust
Steve Jeffery
Professor, Wound Study, Birmingham City University, Fellow of the Royal College of Surgeons of Edinburgh, England and Glasgow
Editor Julie Smith Subeditor Lauran Elsden Associate Publisher Chloe Benson Publishing Director Anthony Kerr If you would like to submit an article for publication in this supplement please contact Julie Smith on 020 7738 5454 or [email protected]
MA Healthcare Ltd is part of the Mark Allen Group
www.markallengroup.com The British Journal of Nursing is published by MA Healthcare Ltd, St Jude’s Church, Dulwich Road, London SE24 0PB Tel: 020 7738 5454 Editorial: 020 7501 6716 Sales: 020 7501 6726 Subscriptions: 0800 137201 Email: [email protected] Websites: www.britishjournalofnursing.com
© MA Healthcare Ltd, 2012. All rights reserved. No part of the British Journal of Nursing may be reproduced, stored in a retrieval system, or transmitted in any form or by any means electronic, mechanical, photocopying, recording, or otherwise without prior written permission of the Publishing Director. Print: Pensord Press Ltd, Blackwood, NP12 2YA Cover picture: istockphoto.com
The paper used within this publication has been sourced from Chain-of-Custody certified manufacturers, operating within international environmental standards, to ensure sustainable sourcing of the raw materials, sustainable production and to minimise our carbon footprint.
T
issue viability has many faces in health care today. We present foremost for patient care, however, our evolving role as specialist, innovator, researcher and advocator continues to demand that we meet expectation for high-quality, evidence-based practice and measurable outcomes. Measuring the domains of quality in wound care and tissue viability services has been outlined in the Department of Health white paper (2010) as safety, effectiveness and experience.While we are confident that we provide care that meets the domain of quality and patient experience, future challenges in promoting and sustaining services will require us to prove we have the specialist skills to operate in our field. As specialists we must meet locally with our fellow tissue viability colleagues and nationally to share and learn from each other. The NHS demands more effective and efficient use of its resources in conjunction with greater budgetary constraints, both of which have impacted upon availability and access to wound-care education (Ousey et al, 2011). The consequence of increasing constraints to reduced access and funds to education and training can be transferred to patient outcomes and in reaction to this we have had to find other ways of outsourcing flexible education and training. The wound-care industry has responded to this with the introduction of non-promotional clinical teams, demonstrating a commitment beyond sales figures. This ‘value-added service’ has provided much-needed support to tissue viability in meeting NHS incentives and the needs of tissue-viability nurses. Questions will always arise between industry and clinician in terms of motivation, bias and credibility, however, we cannot overlook that industry play a pivotal role in often providing the framework to how we access education. Industry is actively involved in many of our tissue viability forums and bring new dimensions and productivity to how we manage and implement. A key example of this is the new consensus document Effective debridement in a changing NHS (2013), which provides us with the theory and practical steps to effectively facilitate optimum wound healing through debridement. With the release of this seminal document we had begun to question our own skills and competencies; were they up to date and valid, were they universityaccredited, did we need an update?
British Journal of Nursing, 2013 (Tissue Viability Supplement), Vol 22, No 12
An exciting opportunity arose this year in London and the South East where industry and clinician came together to propose new ways of developing sharp debridement skills; this was in response to a lack of formal accredited training within the London area. Chair for the Tissue Viability Nurse Forum South, (TVNFS) Kumal Rajpaul approached the clinical team from Urgo Medical to work together to develop a new sharp-debridement course.The development of the course was based on a university module, however, it demanded a fresh approach to accommodate training around new study-leave allowances.The revised course was based on condensing the taught sessions into 3 days and basic knowledge was delivered in the form of a precourse reading manual.These adaptations underwent peer review from forum members periodically and any changes were made by the collaborative efforts of both TVNFS and the clinical support from Urgo Medical. The course was later submitted to EWMA for endorsement as valid for sharp-debridement training and received its primary approval in April 2013. Feedback was extremely positive and while the first 15 attendees are currently working on their competencies, the waiting list for the next course is already growing. The course is recognised as a vital part of wound education for specialist nurses in providing high-quality care for patients, ultimately delivering improved patient outcomes. It has also opened up new possibilities for those of us involved in tissue viability forums; we have the skills to share and learn from each other so firstly let us consider what we can offer in terms of skill development and specialist placement and competency. Patient care is about excellence and who better to teach this than those BJN of us who provide it. Department of Health (2010) Equity and excellence. Liberating the NHS. DH, London Ousey K et al (2011) How can we maintain effective and relevant wound care education? Wounds UK. 7(1): 145-7 Wounds UK (2013) Effective debridement in a changing NHS: a UK consensus. Wounds UK, London
Jemell Geraghty Jemell is Clinical Nurse Specialist in Tissue Viability, the Royal Free Hampstead NHS Trust
S3
British Journal of Nursing. Downloaded from magonlinelibrary.com by 130.194.020.173 on November 26, 2015. For personal use only. No other uses without permission. . All rights reserved.
